Infinium Pharmachem Reports Strong H1 FY27 Performance
Infinium Pharmachem Ltd · Outcome · 06 Nov 2026, 6:53 pm
Infinium Pharmachem Reports Strong H1 FY27 Performance Infinium Pharmachem reported a 54.3% YoY rise in consolidated revenue from operations to ₹129.72 cr for the half year ended 30th Sep'26, compared to ₹84.05 cr in H1 FY26. Consolidated profit after tax attributable to owners grew 59.4% YoY to ₹8.93 cr from ₹5.60 cr, with diluted EPS improving to ₹5.73 from ₹3.59. On a standalone basis, revenue reached ₹112.01 cr, up 54.3% YoY, while net profit rose 58.2% YoY to ₹7.34 cr. Operating cash flow strengthened significantly to ₹7.40 cr.
Original exchange filing (PDF)
More announcements from Infinium Pharmachem Ltd
- INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 06 Nov 2026
- To consider and approve the half year financial results for the period ended September 30, 2026 · 06 Nov 2026
- Quarterly Compliance for Integrated Governance for quarter ended 30.09.2026 · 09 Oct 2026
- Infinium Pharmachem Limited has informed the Exchange regarding 'Submission of Annual Secretarial Compliance Report for purpose of Migration from NSE Emerge to Main Board of NSE'. · 30 Sept 2026
- Infinium Pharmachem Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. · 29 Sept 2026
- Infinium Pharmachem Limited has informed the Exchange about Credit Rating- New · 22 Sept 2026
- Infinium Pharmachem Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 17, 2026. Further, the company has informed the Exchange regarding voting results. · 19 Sept 2026
- Infinium Pharmachem Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 17, 2026 · 17 Sept 2026
